Suchergebnisse - "DiNicolantonio, James J"

PubPharm (308)

1

Nutraceutical activation of Sirt1 : a review

enthalten in: Open heart | 2022

von DiNicolantonio, J. | McCarty, M. | O'Keefe, J.

2

Added Sugars Drive Insulin Resistance, Hyperinsulinemia, Hypertension, Type 2 Diabetes and Coronary Heart Disease

enthalten in: Missouri medicine | 2022

von DiNicolantonio, J. | O'Keefe, J.

3

Nutraceutical Prevention of Diabetic Complications-Focus on Dicarbonyl and Oxidative Stress

enthalten in: Current issues in molecular biology | 2022

von McCarty, M. | DiNicolantonio, J. | O'Keefe, J.

4

Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration

enthalten in: Nutrients | 2022

von Lewis Luján, L. | McCarty, M. | Di Nicolantonio, J. | +4

5

Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity

enthalten in: Open heart | 2022

von DiNicolantonio, J. | McCarty, M. | Assanga, S. | +2

6

Coenzyme Q10 deficiency can be expected to compromise Sirt1 activity

enthalten in: Open heart | 2022

von DiNicolantonio, J. | McCarty, M. | O'Keefe, J.

7

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes

enthalten in: Open heart | 2022

von DiNicolantonio, J. | H O'Keefe, J.

8

Monounsaturated Fat vs Saturated Fat : Effects on Cardio-Metabolic Health and Obesity

enthalten in: Missouri medicine | 2022

von DiNicolantonio, J. | O'Keefe, J.

9

Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity-Nutraceutical Options

enthalten in: Healthcare (Basel, Switzerland) | 2021

von McCarty, M. | DiNicolantonio, J.

10

Low-grade metabolic acidosis as a driver of chronic disease : a 21st century public health crisis

enthalten in: Open heart | 2021

von DiNicolantonio, J. | O'Keefe, J.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]